Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

Status of the NF1 tumor suppressor locus in uveal melanoma.

Foster WJ, Fuller CE, Perry A, Harbour JW.

Arch Ophthalmol. 2003 Sep;121(9):1311-5.

PMID:
12963615
2.

Proteomics of uveal melanomas suggests HSP-27 as a possible surrogate marker of chromosome 3 loss.

Coupland SE, Vorum H, Mandal N, Kalirai H, Honoré B, Urbak SF, Lake SL, Dopierala J, Damato B.

Invest Ophthalmol Vis Sci. 2010 Jan;51(1):12-20. doi: 10.1167/iovs.09-3913. Epub 2009 Jul 30.

PMID:
19643972
3.

Status of RASSF1A in uveal melanocytes and melanoma cells.

Calipel A, Abonnet V, Nicole O, Mascarelli F, Coupland SE, Damato B, Mouriaux F.

Mol Cancer Res. 2011 Sep;9(9):1187-98. doi: 10.1158/1541-7786.MCR-10-0437. Epub 2011 Jul 25.

4.

Expression of p53-induced apoptosis effector PERP in primary uveal melanomas: downregulation is associated with aggressive type.

Paraoan L, Gray D, Hiscott P, Ebrahimi B, Damato B, Grierson I.

Exp Eye Res. 2006 Oct;83(4):911-9. Epub 2006 Jun 19.

PMID:
16784742
5.

NF1 and Neurofibromin: Emerging Players in the Genetic Landscape of Desmoplastic Melanoma.

Mahalingam M.

Adv Anat Pathol. 2017 Jan;24(1):1-14. Review.

PMID:
27941538
6.

Expression of angiogenic factors Cyr61 and tissue factor in uveal melanoma.

Walker TM, Van Ginkel PR, Gee RL, Ahmadi H, Subramanian L, Ksander BR, Meisner LF, Albert DM, Polans AS.

Arch Ophthalmol. 2002 Dec;120(12):1719-25.

PMID:
12470148
7.

Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma.

Hearle N, Damato BE, Humphreys J, Wixey J, Green H, Stone J, Easton DF, Houlston RS.

Invest Ophthalmol Vis Sci. 2003 Feb;44(2):458-62.

PMID:
12556369
8.

High frequency of submicroscopic hemizygous deletion is a major mechanism of loss of expression of PTEN in uveal melanoma.

Abdel-Rahman MH, Yang Y, Zhou XP, Craig EL, Davidorf FH, Eng C.

J Clin Oncol. 2006 Jan 10;24(2):288-95. Epub 2005 Dec 12.

PMID:
16344319
9.

Heat shock protein expression in the eye and in uveal melanoma.

Missotten GS, Journée-de Korver JG, de Wolff-Rouendaal D, Keunen JE, Schlingemann RO, Jager MJ.

Invest Ophthalmol Vis Sci. 2003 Jul;44(7):3059-65.

PMID:
12824252
10.

Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma.

Koopmans AE, Verdijk RM, Brouwer RW, van den Bosch TP, van den Berg MM, Vaarwater J, Kockx CE, Paridaens D, Naus NC, Nellist M, van IJcken WF, Kiliç E, de Klein A.

Mod Pathol. 2014 Oct;27(10):1321-30. doi: 10.1038/modpathol.2014.43. Epub 2014 Mar 14.

11.

A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.

Esposito T, Piluso G, Saracino D, Uccello R, Schettino C, Dato C, Capaldo G, Giugliano T, Varriale B, Paolisso G, Di Iorio G, Melone MA.

J Neurochem. 2015 Dec;135(6):1123-8. doi: 10.1111/jnc.13396. Epub 2015 Nov 12.

12.

Lack of BRAF mutations in uveal melanoma.

Rimoldi D, Salvi S, Liénard D, Lejeune FJ, Speiser D, Zografos L, Cerottini JC.

Cancer Res. 2003 Sep 15;63(18):5712-5.

13.

Multiplex fluorescence in situ hybridization identifies novel rearrangements of chromosomes 6, 15, and 18 in primary uveal melanoma.

Sisley K, Tattersall N, Dyson M, Smith K, Mudhar HS, Rennie IG.

Exp Eye Res. 2006 Sep;83(3):554-9. Epub 2006 May 8.

PMID:
16684523
14.

Cripto-1 expression in uveal melanoma: an immunohistochemical study.

Mallikarjuna K, Vaijayanthi P, Krishnakumar S.

Exp Eye Res. 2007 Jun;84(6):1060-6. Epub 2007 Feb 7.

PMID:
17412323
15.

Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma.

Maat W, Beiboer SH, Jager MJ, Luyten GP, Gruis NA, van der Velden PA.

Invest Ophthalmol Vis Sci. 2008 Apr;49(4):1291-8. doi: 10.1167/iovs.07-1135.

PMID:
18385040
16.

Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.

Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.

Invest Ophthalmol Vis Sci. 2002 Sep;43(9):2845-51.

PMID:
12202501
17.

Mutations in the neurofibromatosis 1 gene in sporadic malignant melanoma cell lines.

Andersen LB, Fountain JW, Gutmann DH, Tarlé SA, Glover TW, Dracopoli NC, Housman DE, Collins FS.

Nat Genet. 1993 Feb;3(2):118-21.

PMID:
8499944
18.

Insulin-like growth factor-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential therapeutic target.

All-Ericsson C, Girnita L, Seregard S, Bartolazzi A, Jager MJ, Larsson O.

Invest Ophthalmol Vis Sci. 2002 Jan;43(1):1-8.

PMID:
11773005
19.

p53 gene and cell cycling in uveal melanoma.

Kishore K, Ghazvini S, Char DH, Kroll S, Selle J.

Am J Ophthalmol. 1996 May;121(5):561-7.

PMID:
8610800
20.

Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.

Coupland SE, Bechrakis N, Schüler A, Anagnostopoulos I, Hummel M, Bornfeld N, Stein H.

Br J Ophthalmol. 1998 Aug;82(8):961-70.

Supplemental Content

Support Center